Dr. Jay Nelson has a collection of HCMV strains available for licensing as a package or on an individual strain basis. The full list of strains which are available are listed under OHSU Technology #1221. These are all clinical isolates that are at early passage and have not been adapted to any cell type and should therefore retain both endothelial and epithelial cell tropism. These strains are useful for a variety of research applications in the field of HCMV.
The particular strain under OHSU 1221-C is the Davis strain.
Inventor ProfileDr. Jay Nelson joined the Oregon Health & Science University as a Professor in the Department of Molecular Microbiology and Immunology in 1992. He was also the Head of Pathobiology and Immunology at the Oregon National Primate Research Center from 1998 to 2000. He is currently the Director of the Vaccine and Gene Therapy Institute and holds joint appointments at the Oregon National Primate Research Center and the Department of Molecular Microbiology and Immunology.
Licensing OpportunityThe Davis strain is currently available for non-exclusive licensing as a research tool.